Binge Drinking, Alone or With Cannabis, During Adolescence Triggers Different Effects on Immediate Visual Memory in Men and Women
Department of Psychobiology, University of Valencia, Valencia, Spain
*Correspondence: Concepción Vinader-Caerols concepcion.vinader@uv.esAbstract
Background: This study examines the interaction between a history of binge drinking (BD), alone or with cannabis consumption, and the effects of acute alcohol exposure on immediate visual memory (IVM) (faces memory task, scenes memory task and IVM-IQ) in adolescents of both sexes.
Method: Two hundred and ninety adolescents, grouped into refrainers, binge drinkers and subjects with a history of simultaneous BD/Cannabis co-use, received a risk dose of alcohol or a control drink.
Results: Consumption Pattern (refrainers vs. binge drinkers vs. BD/Cannabis consumers) was not significant, while Treatment (acute alcohol vs. control drink) was significant in both sexes. Also, male binge drinkers' performance in the faces memory task was poorer than that of refrainers and BD/Cannabis consumers who consumed the control drink. BD/Cannabis consumers performed this task as capably as refrainers. In women, binge drinkers performed better than refrainers in scene memory and IVM-IQ tests when given alcohol, and binge drinkers performed worse than refrainers after consuming the control drink.
Conclusions: Acute alcohol consumption worsens IVM. Cannabis exerts a buffering effect in men. A cognitive tolerance effect is observed in women. Exposure during adolescence to alcohol, alone or with cannabis, can trigger different cognitive effects in men and women that could endure into adulthood.
Introduction
We have previously observed differential effects of alcohol on memory performance in adolescent binge drinkers, with immediate visual memory (IVM) proving to be particularly sensitive to impairment by alcohol (1, 2). The prevalent pattern of alcohol use among adolescents and young adults in Western countries is binge drinking (BD), which has been defined by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) as a pattern of drinking that raises a person's blood alcohol concentration (BAC) to 0.8 g/L or above (3). This pattern is characterized by intermittent consumption of large quantities of alcohol in short periods at intervals of between 1 week and 1 month and alternation between intoxication and withdrawal (4–6).
Researchers have investigated the effects of BD on different kinds of memory. Among them, word fragment completion, free recall, and IVM appear to be the most sensitive in adolescents and young adults, as they are affected by moderate doses of alcohol (BAC = 0.3 −0.38 g/L) [e.g., (2, 7)]. Higher doses of alcohol (BAC levels of BD, i.e., around 0.8 g/L) are necessary for this significant impairment to be observed with other types of memory, such as working memory [e.g., (1)] and short-term memory [e.g., (8)]. A plausible explanation for the lack of effects reported with BACs under 0.8 g/L [e.g., (8–10)] is that the brain of binge drinkers employs compensatory mechanisms in additional brain areas in order to perform tasks adequately, and that these resources are undermined by higher BACs [e.g., (11)].
On the other hand, according to a report from the Spanish Observatory of Drugs and Addictions (12), 13.4% of the Spanish adolescents who consumed alcohol during the last year also used cannabis, while 91.7 % of those who used cannabis also claimed to drink alcohol. This indicates that almost all cannabis users are co-users of alcohol.
The effects of alcohol and cannabis co-use on cognitive functions have been the subject of less research, and are more ambiguous than those of these substances when consumed alone. Some authors (13–15) consider that cannabis tempers the deteriorating effect of alcohol on cognitive functions, while others (16, 17) argue for a synergistic effect of cannabis on the deteriorating effect of alcohol on memory. In addition, there are no studies that have evaluated the phenomenon of cognitive tolerance in alcohol and cannabis co-users, a phenomenon observed in female alcohol users (2).
Experimental results of research performed with subjects of a single sex are sometimes extrapolated to both sexes. Sex should be considered as an important biological variable in basic and preclinical research, and results should not be automatically applied to both men and women (18). Sex differences in the effects of alcohol have been reported, supporting the view that the brains of male and female adolescents are differentially affected by alcohol use (19). There is evidence suggesting that female adolescents are more vulnerable to the neurotoxic effects of alcohol on cognition (19, 20), since the cognitive tolerance effect of alcohol on IVM develops in BD women but not in BD men (2). Several studies have demonstrated the differential associations of alcohol and cannabis co-use with the neurocognitive functioning of males and females, showing a different pattern of neurocognitive impairment in men and women [e.g., (21)]. In the light of these data, we deem it crucial to include both sexes in this study.
Taking into account the scarcity of studies evaluating the cognitive effects of alcohol and cannabis co-use in healthy adolescents, and considering the potential vulnerability of females to the neurotoxic effects of alcohol, the main objective of this research was to study experimentally the interaction between a history of BD, alone or simultaneously with cannabis use, and the effects of acute alcohol exposure on IVM (faces memory, scenes memory and IVM-IQ) in adolescents of both sexes. IVM was assessed by the Wechsler Memory Scale 3rd Edition (22), as it is a standard clinical instrument commonly used for evaluating this type of memory. Based on previous works, we already know that some long-term effects of repeated alcohol exposure in adolescents (such as alcohol tolerance or damaged cognitive abilities) are manifested more readily following ingestion of an acute dose of alcohol. Our hypotheses are: (1) A history of consumption and/or acute alcohol consumption would produce an impairment of IVM with sex-differential effects, being more evident in women than in men; (2) A synergistic effect could be observed vs. a buffering effect of cannabis on the detrimental effect of alcohol, which may also be sex-dependent.
Methods
Subjects
Two hundred and ninety 18–19 years old adolescent students (one hundred and eighteen males and one hundred and seventy-two females) from the University of Valencia, Spain, filled in a self-report questionnaire about physical and psychological health, frequency and level of consumption of alcohol, cannabis, alcohol with cannabis, or other drugs, and hours and quality of sleep. The participants were recruited for the study based on strict exclusion and inclusion criteria. The exclusion criteria were as follows: taking medication; a history of mental disorders (diagnosed by a health professional according to DSM criteria); an irregular sleep pattern (non-restorative sleep and/or irregular schedule); having consumed, even sporadically, any drug or having a history of substance use (including those studied herein); and having first-degree relatives with drug misuse problems. The following inclusion criteria were used: age 18–19 years old; a healthy body mass index (mean in men: 22.61 ± 0.24, mean in women: 21.55 ± 0.2); good health (without major medical problems); and being refrainers, occasional consumers of alcohol, binge drinkers or BD and cannabis co-users. The participants were classified as refrainers if they had never consumed alcoholic drinks or had drunk very sporadically. They were classified as alcohol consumers with a BD pattern in accordance with the NIAAA criteria for Spain [see (23)], i.e., if they had drunk six or more standard drink units (SDU = 10 g of alcohol) of distilled spirits (alcohol content ≥ 40 vol. %) in a short of period of time in the case of men, and five or more SDU in the case of women, at a minimum frequency of three occasions per month, throughout the previous 12 months (6). Finally, the participants were classified as co-users if they reported a pattern of BD along with cannabis use (i.e., they usually smoked a joint while they have an episode of BD). In fact, alcohol consumption is widespread among adolescents who use cannabis (in Spain, 91.7% who smoke cannabis also drink alcohol) (12).
The participants were told to follow their normal sleep pattern and meal routine, and to eat 1 h before the experimental session.
A telephone interview of approximately 15 min was conducted with each subject in order to confirm the information previously provided in the self-report and to fix a date and time for the test session. The participant's data were verified again on the test day. The data concerning the menstrual cycles of the female groups were registered in the self-report and during the telephone interview, and cycle phase was considered in the test in order to counterbalance this variable in each group.
Test and Apparatus
The Alcohol Use Disorders Identification Test (AUDIT) (24) was employed to determine a problematic use of alcohol among the subjects. AUDIT is considered an appropriate screening instrument to classify BD and non-BD university students (25). The AUDIT consists of 10 questions that evaluate the quantity and frequency of alcohol intake, as well as alcohol-related behaviors and their consequences.
The Cannabis Abuse Screening Test (CAST) (26) is a six-item self-report that we employed to detect a problematic use of cannabis among the subjects during the previous 12 months.
A digital automatic blood pressure monitor (M10-IT, OMRON, Spain) was employed to register systolic and diastolic blood pressure and heart rate in all the subjects.
An alcoholmeter (Alcoquant® 6020, Envitec, Germany) was employed to evaluate BAC before and after (20 and 50 min) drink intake.
A drug test (DrugTest® 5000, Dräger, Spain) was employed to analyze the presence of drugs in a saliva sample collected from each participant before drink intake.
IVM was assessed using the Wechsler Memory Scale 3rd Edition (WMS–III; version adapted for the Spanish population) (22). The IVM subscales require the respondent to recognize faces (faces memory) and remember scenes (scenes memory). Specifically, in the faces memory task, the participants are shown 24 target faces, one at a time for 2 s. Then participants are shown 48 faces (24 targets and 24 distractors) and are asked to identify the target faces by responding either “yes” or “no” to each face. In the scenes memory task, the participants view four different scenes of four family members engaged in a common activity (such as buying clothing). After viewing all four scenes, the participants are shown a card divided into four quadrants, given the name of the scene, and asked to recall it, indicating where each family member was located in the original picture and what that family member was doing. Subjects' scores on the IVM scales (0–20 scalar scores were used both in face and scene memory tests) were transformed into centiles according to the subject's age to obtain the IQ of IVM.
Procedure
The experimental procedure was approved by the Research Ethics Committee of the University of Valencia (Certification number: H1485172642673; approved on July 7th, 2017), and was in accordance with the Helsinki Agreement. All the subjects provided written informed consent to participate in the study. According to their Consumption Pattern (Refrainers, Binge Drinkers and BD/Cannabis consumers) and the Treatment received (Control drink and Alcohol), the participants were assigned to one of six experimental conditions for each sex: Refrainers-Control drink (R-Co); Refrainers-Alcohol (R-A); Binge Drinkers-Control drink (BD-Co); Binge Drinkers-Alcohol (BD-A); BD/Cannabis-Control drink (BD/C-Co) and BD/Cannabis-Alcohol (BD/C-A).
The participants were instructed to abstain from any intake of alcohol, caffeinated beverages, drugs or medication and strenuous exercise for 24 h before the experimental session, and to refrain from eating and smoking at least 1 h prior to the session. At the beginning of the experimental session BAC was measured in BD and co-user subjects using the alcoholmeter to ensure that they had not consumed alcohol. A saliva sample of the co-users was also analyzed by the drug test to make sure that they had not used other drugs.
In addition, a problematic use of alcohol or cannabis among the BD subjects and co-users was assessed using the AUDIT and CAST test, respectively. None of the subjects was found to be alcohol or cannabis-dependent (mean AUDIT: 8.35 ± 0.39 in men; 7.3 ± 0.28 in women; mean CAST: 2.83 ± 0.38 in men; 2.57 ± 0.28 in women). Next, each subject received a flavored refreshment (lime, orange or cola, without caffeine) contained in cans of 330 ml, alone or mixed (according to the experimental group) with distilled drinks of alcohol content = 40% vol. (vodka or gin) at a risk dose of 120 ml (equivalent to 38.4 g of alcohol). The subjects were instructed to consume their drink within a period of 20 min. The participants ate a light snack (the same for all the participants) and the beverages were always consumed in the presence of a research assistant. After finishing the drink, all the subjects rinsed their mouths with water, and BAC was repeatedly measured every 5 min throughout the waiting period, until it peaked (~20 min after consuming the drink). The subjects performed the IVM tests, faces memory test and scenes memory test, in a counterbalanced manner, while BAC was descending. The BAC of each experimental subject was measured again at end of the experiment.
BAC was 0.00 g/L for men and women before the alcoholic drink, and was 0.36 ± 0.008 g/L for men and 0.53 ± 0.01 g/L for women afterwards. It is important to point out that, although all the subjects consumed the same amount of alcohol, the statistical differences in BAC between men and women did not allow a direct comparison between the sexes. On the other hand, it was possible to study the effects of alcohol on each sex.
Statistical Analyses
Data from men and women were analyzed separately, as BAC was found to be statistically different between the two sexes. The data were submitted to parametric analysis after checking that they met the criteria for normality and homogeneity of variances. Each analysis (faces memory, scenes memory and IVM-IQ) contained the between-subject factors Consumption Pattern (Refrainers, Binge Drinkers and BD/Cannabis consumers) and Treatment (Control drink and Alcohol). When their interaction was statistically significant, pairwise comparisons were carried out. All analyses were performed using the “SPSS” Statistics software package, version 26.0 for Windows (27).
Results
IVM in Men (BAC: 0.36 ± 0.008 g/L)
Table 1 shows a summary of descriptive statistics and significant differences observed among men with respect to Consumption Pattern and Treatment in the faces memory task, scenes memory task and IVM-IQ.
| Consumption pattern | Treatment | ||||||
|---|---|---|---|---|---|---|---|
| Men | Refrainers (n = 38) | Binge Drinkers (n = 50) | BD/Cannabis consumers (n = 30) | Statistical Powera / Eta2 | Control drink (n = 65) | Alcohol (n = 53) | Statistical Powera / Eta2 |
| Faces memory | 8.44 ± 0.37 | 7.44 ± 0.34 | 8.6 ± 0.57 | 0.352 / 0.03 | 8.75 ± 0.33 | 7.2 ± 0.32*** | 0.96 / 0.111 |
| Scenes memory | 9.39 ± 0.61 | 9.7 ± 0.51 | 8.76 ± 0.72 | 0.142 / 0.01 | 9.93 ± 0.42 | 8.66 ± 0.55 | 0.362 / 0.023 |
| IVM-IQ | 95.00 ± 2.35 | 92.780 ± 2.01 | 93.33 ± 3.11 | 0.096 / 0.005 | 97.36 ± 1.68 | 89.05 ± 2.12** | 0.861 / 0.078 |
| Consumption pattern | Treatment | ||||||
| Women | Refrainers (n = 56) | Binge Drinkers (n = 80) | BD/Cannabis consumers (n = 36) | Statistical Powera / Eta2 | Control drink (n = 100) | Alcohol (n = 72) | Statistical Powera / Eta2 |
| Faces memory | 8.83 ± 0.39 | 8.61 ± 0.35 | 9.91 ± 0.47 | 0.182 / 0.009 | 9.91 ± 0.27 | 7.63 ± 0.35*** | 0.992 / 0.104 |
| Scenes memory | 9.33 ± 0.42 | 8.77 ± 0.38 | 9.02 ± 0.55 | 0.08 / 0.002 | 9.69 ± 0.3 | 8.06 ± 0.41* | 0.761 / 0.042 |
| IVM-IQ | 95.94 ± 1.96 | 93.62 ± 1.58 | 98.16 ± 2.35 | 0.168 / 0.008 | 100.04 ± 1.28 | 88.79 ± 1.68*** | 0.995 / 0.111 |
Faces Memory
There was no significant main effect of Consumption Pattern on performance [F(2, 112) = 1.705, ns]. The factor Treatment was statistically significant [F(1, 112) = 14.007, p < 0.001], with subjects given alcohol showing lower scores than those given the control drink (see Table 1). The interaction Consumption Pattern X Treatment was also statistically significant [F(2, 112) = 3.523, p < 0.05]. Post hoc comparisons showed that the R-A and BD/C-A groups performed worse than the R-Co and BD/C-Co groups, respectively (ps < 0.05); and that the BD-Co group performed worse than the R-Co and BD/C-Co groups (ps < 0.05), while no differences were detected between the last two groups (see Figure 1).
Scenes Memory
The factors Consumption Pattern [F(2, 112) = 0.567, ns] and Treatment [F(1, 112) = 2.622, ns] were not statistically significant, and neither was their interaction [F(2, 112) = 0.812, ns].
IVM-IQ
There was no significant main effect of Consumption Pattern on performance [F(2, 112) = 0.294, ns]. The factor Treatment was statistically significant [F(1, 112) = 9.431, p < 0.005], with subjects given alcohol showing lower IVM-IQ than those given the control drink (see Table 1). The interaction Consumption Pattern X Treatment was not statistically significant [F(2, 112) = 0.105, ns].
IVM in Women (BAC: 0.53 ± 0.01 g/L)
Table 1 shows a summary of descriptive statistics and significant differences observed among women in terms of the factors Consumption Pattern and Treatment in the faces memory task, scenes memory task and IVM-IQ.
Faces Memory
There was no significant main effect of Consumption Pattern on performance [F(2, 166) = 0.785, ns]. The factor Treatment was statistically significant [F(1, 166) = 19.302, p < 0.001], with subjects given alcohol scoring lower than those given the control drink (see Table 1). The interaction Consumption Pattern X Treatment was not statistically significant [F(2, 166) = 0.341, ns].
Scenes Memory
There was no significant main effect of Consumption Pattern on performance [F(2, 166) = 0.182, ns]. The factor Treatment was statistically significant [F(1, 166) = 7.203, p < 0.01], with subjects given alcohol obtaining lower scores than those given the control drink (see Table 1). The interaction Consumption Pattern X Treatment was also statistically significant [F(2, 166) = 8.167, p < 0.001]; the R-A group performed worse than the R-Co group, and BD-Co and BD/C-Co participants performed worse than the R-Co subjects, while the BD-A group performed better than the R-A group (ps < 0.05) (see Figure 2).
IVM-IQ
There was no significant main effect of Consumption Pattern on performance [F(2, 166) = 0.707, ns]. The factor Treatment was statistically significant [F(1, 166) = 20.733, p < 0.001], with subjects receiving alcohol displaying lower IVM-IQ than those given the control drink (see Table 1). The interaction Consumption Pattern X Treatment was also statistically significant [F(2, 166) = 5.051, p < 0.01], with the R-A group performing worse than the R-Co group, the BD-Co group performing worse than R-Co subjects, and the BD-A group outperforming the R-A group (ps < 0.05) (see Figure 3).
Discussion
A distinctive contribution of this study is to evaluate experimentally, together, the impact of an acute alcohol consumption episode and a BD history of consumption on IVM (faces memory, scenes memory and IVM-IQ) in adolescent men and women. We could not directly examine sex differences in IVM functioning among our adolescent population, but our study provides interesting data for each sex.
We have observed that a moderate acute dose of alcohol (BAC = 0.36 g/L in men and 0.53 g/L in women) is enough to impair faces memory and IVM-IQ in men, and faces and scenes memory and IVM-IQ in women, and corroborate that IVM is sensitive to the neurotoxic effects of acute alcohol consumption (2, 7). However, the maintenance of a BD pattern for 1 year did not affect IVM in any sex.
The literature suggests that this BD pattern and its maintenance over time have differential effects on memory (28). In the longitudinal study of Carbia et al. (28) executive difficulties disappeared after maintaining a BD pattern of alcohol consumption for 2 years (which was interpreted as an improvement), and the authors proposed than an alcohol-related delay in neuro-maturation, principally affecting prefrontal regions, resulted in BD subjects gaining executive efficiency later than age-matched non-BD individuals.
The pattern of alcohol and cannabis co-use did not affect the IVM in our study. Simultaneous alcohol and cannabis use in young drinkers (18–25 years old) has been associated with an increase of negative consequences (29). The existing literature on the effects of simultaneous alcohol and cannabis consumption on memory is scarce and contradictory. On the one hand, a synergistic deteriorating effect of alcohol and cannabis on cognitive processes has been reported (16, 17), with co-users being more likely to experience more severe cognitive consequences than users of alcohol alone (30). On the other hand, a buffering effect of cannabis against the deteriorating effects of alcohol on memory has been demonstrated by other researchers (13, 14). Cannabidiol (CBD) is a component of the cannabis plant with anti-inflammatory properties whose ability to improve cognitive impairment has been explored to an extent, but not conclusively. Nevertheless, authors such as Osborne et al. (31) have shown that CBD improves cognition in multiple preclinical models of cognitive impairment, including those of neuropsychiatric (schizophrenia), neurodegenerative (Alzheimer's disease), neuro-inflammatory (meningitis, sepsis and cerebral malaria) and neurological (hepatic encephalopathy and brain ischemia) disorders.
In line with the aforementioned evidence, we have observed, after a previous year of simultaneous consumption, a dampening effect of cannabis on the deteriorating effects of alcohol in the faces memory test when performed by men. After receiving the control drink, co-users performed this task as well as refrainers, while participants with a BD history performed worse than refrainers and co-users. It is plausible that the neuro-inflammatory effects of alcohol, responsible for cognitive decline, were counteracted by the anti-inflammatory efficacy of cannabis. Nevertheless, as other authors (14) have pointed out, long-term use of these substances can negatively increase vulnerability to the development of addictions. Furthermore, it must be taken into account the timeframe of consumption of these substances, as it is associated with the cognitive impairment (32).
In women, the interaction Consumption Pattern X Treatment was statistically significant with respect to scenes memory and IVM-IQ, and alcohol generated an effect of cognitive tolerance. This suggests that our binge drinkers developed tolerance in such a way that the deteriorating effect of alcohol on their scenes memory and IVM-IQ after drinking alcohol was weaker than that seen in refrainers. Thus, binge drinkers performed better than refrainers when given alcohol (displaying the abovementioned development of alcohol tolerance) and binge drinkers performed worse than refrainers after consuming a control drink (as their memory would have been damaged). The existence of this cognitive tolerance is endorsed by the fact that the scenes memory and IVM-IQ of female binge drinkers receiving the alcoholic drink did not differ from those of binge drinkers given the control drink. This phenomenon of cognitive tolerance was not so obvious in co-users, since there were differences in scenes memory between refrainers and co-users who received the control drink, but there were no differences in scenes memory or in IVM-IQ between refrainers and co-users who received alcohol. On the other hand, the phenomenon of women beginning to drink earlier and progressing more rapidly than men from the first exposure to the addiction phase, known as the “telescoping effect” (33–35), could explain why adolescent women develop cognitive tolerance earlier than men.
The alcohol acutely consumed by the participants in our study (38.4 g of alcohol) was close to the so called “risky alcohol consumption” for men and women (>5 SDU for men, and >4 SDU for women; 50 and 40 g of alcohol, respectively) (36). Some of the different effects observed in men and women in our study could be explained by the differences in BAC between the sexes in our population. It is possible that cognitive tolerance to alcohol would also be observed in male subjects with a higher BAC. This brings us to a limitation of our study, as the statistical differences in BAC between men and women did not allow a direct comparison between sexes. In this context, identifying gender-specific effects of alcohol and cannabis on male and female adolescents separately may help to explain differential proneness to substance use in adolescents (21). Acute alcohol consumption vs. a history of BD pattern leads to differential effects on cognition that depend on the type of memory in question. In conclusion, exposure during adolescence to alcohol, alone or with cannabis, can trigger different cognitive effects in men and women, which contribute to enduring cognitive deficits in adulthood. Moreover, our findings are consistent with the greater vulnerability of adolescent women to the neurotoxic effects of alcohol. Further research is needed–particularly, longitudinal studies including women and exploring the timeframe of consumption of these substances–in order to confirm the aforementioned findings and consolidate our conclusions. This will allow us to better understand the mechanisms underlying the effects on memory of alcohol, consumed alone or simultaneously with cannabis, and to develop optimal treatment methods for cannabis /alcohol dependence in men and women.
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics Statement
The studies involving human participants were reviewed and approved by Research Ethics Committee of the University of Valencia (Certification number: H1485172642673; approved on July 7th, 2017). The patients/participants provided their written informed consent to participate in this study.
Funding
This work was supported by the Universitat de València (Grant UV-INV_AE18-779336) and Generalitat Valenciana (Grant PROMETEO-II/2015/020), Spain.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgements
The authors wish to thank Mr. Brian Normanly for his editorial assistance.